Therapeutics Lifecycle SIG

Join us for a discussion following last month’s presentation on Therapeutic Inertia. On Wednesday we’ll dig further into the three pillars of inertia: patient factors, physician and clinical team factors, and health system factors.

The Therapeutic Lifecycle SIG focuses holistically on the full lifecycle of therapeutic development, from clinical trials to in-market use. Initial work will focus on clinical research, regulatory submission, in-market pharmaceuticals, and connecting research technology solutions to in-market technology solutions.